N

Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707

Watchlist Manager
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707
Watchlist
Price: 13.61 CNY -2.79%
Market Cap: 22B CNY
Have any thoughts about
Nanjing King-friend Biochemical Pharmaceutical Co Ltd?
Write Note

Nanjing King-friend Biochemical Pharmaceutical Co Ltd
Goodwill

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nanjing King-friend Biochemical Pharmaceutical Co Ltd
Goodwill Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Goodwill CAGR 3Y CAGR 5Y CAGR 10Y
N
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707
Goodwill
ÂĄ128.4m
CAGR 3-Years
3%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Goodwill
ÂĄ104.1m
CAGR 3-Years
45%
CAGR 5-Years
25%
CAGR 10-Years
23%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Nanjing King-friend Biochemical Pharmaceutical Co Ltd
Glance View

Market Cap
22B CNY
Industry
Pharmaceuticals

Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. is a holding company that engages in the research, development, manufacture and sale of biochemical pharmaceutical products. The company is headquartered in Nanjing, Jiangsu and currently employs 1,006 full-time employees. The company went IPO on 2017-07-19. The firm's main products include standard heparin raw materials, low molecular weight heparin raw materials and their preparations, such as heparin sodium raw materials, heparin sodium, enoxaparin sodium injection, dalteparin sodium injection and Naqu Heparin Calcium Injection. The firm mainly exports its products to the United States and European countries.

Intrinsic Value
20.65 CNY
Undervaluation 34%
Intrinsic Value
Price
N

See Also

What is Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Goodwill?
Goodwill
128.4m CNY

Based on the financial report for Sep 30, 2024, Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Goodwill amounts to 128.4m CNY.

What is Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Goodwill growth rate?
Goodwill CAGR 3Y
3%

Over the last year, the Goodwill growth was -1%. The average annual Goodwill growth rates for Nanjing King-friend Biochemical Pharmaceutical Co Ltd have been 3% over the past three years .

Back to Top